Activation of caspases and serine proteases during apoptosis induced by onconase (ranpirnase)

Experimental Cell Research

Volumn 278, Issue 1, 2002, Pages 61-71

  Grabarek, Jerzy ^a,b   Ardelt, Barbara ^a   Du, Litong ^a   Darzynkiewicz, Zbigniew ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; Caspases; Cytometry; Cytotoxic RNase; HL 60 cells; Necrobiology; Onconase; Serine proteases; Serpases

Indexed keywords

5(6) CARBOXYFLUORESCEINYLLEUCYL CHLOROMETHYL KETONE; 5(6) CARBOXYFLUORESCEINYLPHENYLALANYL CHLOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CHYMOTRYPSIN; KETONE DERIVATIVE; LEUCINE; LIGAND; PHENYLALANINE; RANPIRNASE; REAGENT; RHODAMINE; SERINE PROTEINASE; SULFORHODAMINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL LABELING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; TIME;

AMPHIBIA;

EID: 0036076883     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5568     Document Type: Article

References (51)

1. Cytostatic and cytotoxic effects of Pannon (P-30 Protein), a novel anticancer agent
2. Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonuclease
3. Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with antitumor activity
4. Natural and engineered cytotoxic ribonucleases: Therapeutic potential
5. Cancer chemotherapy-Ribonucleases to the rescue
6. Enzymatic characterization of onconase, a novel ribonuclease with anti-tumor activity
7. Role of N terminus in RNase A homologues: Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity
8. Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines
9. In vitro synergism between a novel amphibian oocytic ribonuclease (ONCO-NASE) and tamoxifen, lovastatin and cisplatin in human OVCAR-3 ovarian carcinoma cell line
10. Cytotoxic onconase and ribonuclease A chimeras: Comparison and in vitro characteristics
11. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with ONCO-NASE, an antitumor ribonuclease
12. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity
13. Striking increase in survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos
14. Potentiation of tumor necrosis factor induced apoptosis by onconase
15. Tamoxifen and trifluoroperazine (Stelazine) potentiate cytotostatic/cytotoxic effects of P-30 Protein, a novel protein possesing anti-tumor activity
16. Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor
17. Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma
18. KIP and decreased pRb phosphorylation
19. A study of the intracellular routing of cytotoxic ribonucleases
20. Entry into cells and selective degradation of tRNA by a cytotoxic member of the RNase A family
21. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis
22. Caspase activation in response to cytotoxic Rana catesbiana ribonuclease in MCF-7 cells
23. DNA strand breaks occuring during apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors
24. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes
25. 0 cells and is prevented by inhibitors of proteases
26. Effect of protease inhibitors on early events of apoptosis
27. Protease inhibitors block apoptosis at intermediate stages: A compared analysis of DNA fragmentation and apoptotic nuclear morphology
28. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunarubicin
29. Effect of inhibitors of cysteine and serine proteases in anticancer drug-induced apoptosis in gastric cancer cells
30. Activation of chymotrypsin-like serine-protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor
31. Sequential activation of caspases and serine proteases (serpases) during apoptosis
32. Identification of the histidine residue at the active center of trypsin labelled by TLCK
33. Structure and mechanism of chymotrypsin
34. Chymotrypsinogens- Chymotrypsins
35. Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry
36. Laser scanning cytometry
37. Laser scanning cytometry. A new instrumentation with many applications
38. Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-α or camptothecin assayed by the stathmo-apoptosis method
39. Features of apoptotic cells measured by flow cytometry
40. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): Correlation with DNA fragmentation
41. Granzyme release and caspase activation in activated human T-lymphocytes
42. Granzymes (lymphocyte serine proteases): Characterization with natural and synthetic substrates and inhibitors
43. Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation
44. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death
45. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins
46. Localization of acetylcholinesterase activity using a 3H-labeled irreversible inhibitor
47. Specific proteases of mast cells
48. Non-pancreatic proteases of the chymotrypsin family. I. A chymotrypsin-like protease from rat mast cells
49. Autoradiography with tritiated methotrexate and the cellular distribution of folate reductase
50. Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: Relationship to DNA fragmentation and cell cycle position during apoptosis
51. Assays of cell viability: Discrimination of cells dying by apoptosis